肝癌特异蛋白对肝癌诊断价值评价

ASSESSMENT OF THE DIAGNOSIS OF HEPATOCELLULAR CARCINOMA BY SHCSP

通过对不同人群组 75 8例肝癌特异蛋白 (Serum Hepatits Cancer SpecialProtein,SHCSP)检测结果 ;原发性肝癌 SHCSP阳性检出率 89.11% ,高于 AFP检出率 71.2 1% ,统计学处理无显著差异 (P>0 .5 0 0 )。转移肝癌、肝癌术后 ,肝脏良性肿瘤的阳性检出率分别为 79.37%、38.46 %、4.7% ,提示对肝外恶性肿瘤的肝转移及肝癌术后复发转移有监测意义。对慢性肝病 SHCSP阳性者追踪结果显示 ,SHCSP对发现早期肝癌有重要意义。

A total of 758 cases from different groups was detected by SHCSP Test.The results indicated that the positive rate of SHCSP test(89.11%) was higher than that of AFP test ( 71.21% )in hepatocellular carcinoma.The positive rates of metastatic liver cancer,post\|operation liver cancer and hepatic benign tumour by SHCSP test are 79.37%%,38.46% and 4.7% respectively .The results suggested that SHCSP test was significant in monitoring the cancer metastasis from other organs to liver and in controlling the recrudescence and metastasis of post\|operation liver cancer.Tracing observations on the positive cases in chronic hepatic diseases group demonstrated that SHCSP may be useful for detecting early liver cancers.